Clinical Trials
2 trialsNCT05370547 2024-03-06
Chidamide Bridging for CAR-T Therapy
Chinese PLA General Hospital
Phase 1/2 Unknown
NCT04666168 2020-12-14
A Multicenter Clinical Study on the Safety and Efficacy of CAR-T in the Treatment of Relapsed / Refractory Non Hodgkin's Lymphoma
Hebei Senlang Biotechnology Inc., Ltd.
Phase NA Unknown